Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2015

View Archived Issues

Deciphera initiates phase I trial of KIT and PDGFR inhibitor DCC-2618

Copernicus receives FDA orphan drug designation for ABCA4 DNA nanoparticles

Takeda reflects on accomplishments of second quarter of fiscal 2015

InMed provides update on development program for epidermolysis bullosa

Allergan licenses dry eye candidate MIM-D3 from Mimetogen

Cel-Sci's RA vaccine selected for NIH commercialization and niche analysis plan

NIH grant supports City of Hope's research into chronic GvHD

Janssen initiates phase Ib trial of subcutaneous daratumumab in multiple myeloma

Preclinical toxicity study results for Pyridorin will support planned IND filing

New companies created: Evelo Therapeutics, Aziyo Biologics and Iron Horse Therapeutics

Global Health Innovative Technology Fund announces grants for infectious disease research

Ono Pharmaceutical presents update on second quarter of fiscal 2015

SUL-121, a novel candidate to treat diabetic nephropathy

Eisai begins two joint research agreements to develop new antimalarial medicines

IND gets submitted for TD-1473 gastrointestinal-targeted pan-JAK inhibitor from Theravance

New antimalarial strategy shows promising preclinical results

RSV vaccine candidate shows promise for children

Novartis reports autotaxin inhibitors

Gruenenthal patents dual cathepsin K and S inhibitors

HEC Pharm presents PDE4B inhibitors

China State Institute of Pharmaceutical Industry introduces podophyllotoxin derivatives

Australian team divulges Nix-based gene therapies for neurodegeneration

Ignyta licenses rights to Lilly's taladegib oncology program

Antagonism of CCR2/5 in type 2 diabetic nephropathy

Neurocrine starts phase I trial of essential tremor candidate NBI-640756

Transgenomic launches mutation profiling test for NSCLC

FDA accepts for review Amgen's NDA for etelcalcetide

Preliminary phase II results presented for a malaria vaccine adjuvant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...